Mouse iQ Snap Trap

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice

Contains

1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME

Supplemental label elements

EUH210 - Safety data sheet available on request.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII This product is safe with normal use. This product contains a hermetically sealed lithium battery which contains 1,2-dimethoxyethane (EGDME) electrolyte. The electrolyte is full enclosed and is does not result in exposure under normal conditions of use. Risk of exposure occurs only if the battery is mechanically, thermally, or electrically abused and the enclosure is ruptured. If this occurs, exposure to electrolyte can occur by inhalation, ingestion, eye contact, and skin contact. The battery should not be opened, crushed, punctured, or burned. Component Substance(s) not meeting the PBT criteria of REACH 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME (110-71-4) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME (110-71-4) regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME (110-71-4) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.